Boehringer Ingelheim GmbH is one of many pharma companies experimenting with new ways to leverage artificial intelligence (AI) to innovate their ways of distributing information and communicating with patients.
A frontrunner among such firms looking to adopt AI, augmented reality and new digital media tools, it has already identified six areas for implementation and is conducting experiments in three - including a
The private German drug maker is also conducting another experiment to leverage new healthcare influencers via new media. Using visual AI tools such as DALLE-3, it is trialling novel text-to-image systems